Intended for healthcare professionals


Drug-induced localised scleroderma

BMJ 2018; 361 doi: (Published 12 April 2018) Cite this as: BMJ 2018;361:k1326
  1. Yuka Maya, senior resident,
  2. Mitsuhito Ota, dermatologist and director
  1. Department of Dermatology, Chitose City Hospital, Chitose, Japan
  1. Correspondence to M Ota ota{at}

A 70 year old woman presented with skin hardening on her feet. Symptoms had started one month after completing docetaxel, trastuzumab, and pertuzumab chemotherapy for breast cancer. Examination revealed symmetrical, …

View Full Text

Log in

Log in through your institution


* For online subscription